Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by canadafanon Apr 21, 2024 3:34pm
127 Views
Post# 36000344

RE:RE:RE:RE:Canada's 2024 Federal Budget increases capital gains tax

RE:RE:RE:RE:Canada's 2024 Federal Budget increases capital gains tax

Yes, my friend Notable.
Do understand the taxable change will only apply to individual gains above $250,000
What we don't know, is the in- place negotiations.
Assuming for example, they do announce a $5billion buyout.
being about $60/ps.
What is individual is your average cost base?
The math is based on your personal costs. & for obvious reasons , everyone will be different.
repeating my as you say convelouted story. The timing will not be based on tax rules.
consider, they are different for the Nasdaq/ USA holders. & different across various states.
One scinario?
They announce a deal, which might close November.
The announcement would immediately move the price up.
then the shaeholders could sell before the Nov closing date.
The capital gains tax applies to your selling $ - your average cost base.
when sold.not before & not after.
  I would be thrilled to pay taxes above a $250,000 profit!
i do have enough shares to see that number. However split between my spouse & myself.
I sincerely doubt there would be any intentional delays. 
All based on the science & potential income to the aquiring pharma.
canadian taxes are complicated enough. add- in multi country listings.
The fudicuary duty of the B.O.D. Is to oversee that all major decisions are in the best interest of the shareholders.
The tax rule change would only be part if discussions if proposed announced dates were being discussed.
Since disclosure rules indicate public announcements ASAP, they will announce as soon as a proposed deal is reached.
The nasdaq stock holders will not be affected by a Canadian tax rule change.
so, brining tax savings into the calculations is a very complicated process.
IMHO, not  one they will be considering.
Lets end on a positive..think positive.
onc gets bought out $5 billion ++, announced early June. For shareholders to vote on.
FWIW.
assuming a Canadian taxpayer in the 30% marginal rate.
A profit of $500,000 would see  an exiting tax bill go from $75k to $86k
ironically , the mangement with significant marginal tax rate. Probably above 40%. Would see s much higher tax incresse.
that said.
there are many thousand of onc shaeholders  who will not see a dime of tax incresse.
lifetime exemption of $100k. 

need profits above $250,ooo before any change.
I say, bring it on!
 




 

 


 

<< Previous
Bullboard Posts
Next >>